v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Common Stock
Previously Reported
Common Stock
Retroactive application of merger
Common Stock
Preferred Stock (Series B, C and D)
Previously Reported
Preferred Stock (Series B, C and D)
Retroactive application of merger
Preferred Stock (Series B, C and D)
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Retroactive application of merger
Additional Paid-in Capital
Common Stock to be Issued
Previously Reported
Common Stock to be Issued
Retroactive application of merger
Common Stock to be Issued
Accumulated Deficit
Previously Reported
Accumulated Deficit
Retroactive application of merger
Accumulated Deficit
Previously Reported
Retroactive application of merger
Total
Balance at Dec. 31, 2023 $ 1,513 $ 55 $ 1,568 [1] $ 12 $ (12) [1] $ 4,493,881 $ (1,014,473) $ 3,479,408 [1] [1] $ (3,923,677) $ (3,923,677) [1] $ 571,729 $ (1,014,430) $ (442,701) [1]
Balance (in Shares) at Dec. 31, 2023 15,130,393 548,505 15,678,898 [1] 120,000 (120,000) [1]                        
Public warrants assumed from SPAC             488,750         (488,750)    
Private warrants assumed from SPAC             (22,525)             (22,525)
Stock-based compensation     $ 224         2,649,349             2,649,573
Stock-based compensation (in Shares)     2,244,452                              
Conversion of Notes Payable     $ 405         4,164,434             4,164,839
Conversion of Notes Payable (in Shares)     4,050,617                              
Note issuance equity inducement     $ 200         977,800             978,000
Note issuance equity inducement (in Shares)     2,000,000                              
Additional issued shares     $ 298         (298)            
Additional issued shares (in Shares)     2,976,948                              
Issuance of common shares for warrant conversion     $ 13                     13
Issuance of common shares for warrant conversion (in Shares)     130,000                              
Tax fees related to merger             8,517             8,517
Net loss                     (6,150,372)     (6,150,372)
Balance at Dec. 31, 2024     $ 2,708         11,745,436         (10,562,799)     1,185,345
Balance (in Shares) at Dec. 31, 2024     27,080,915                              
Stock-based compensation     $ 101         1,565,111               1,565,212
Stock-based compensation (in Shares)     1,008,691                              
Conversions of debt to equity     $ 801         1,242,679             $ 1,243,480
Conversions of debt to equity (in Shares)     8,013,474                             6,250,000
Issuance of equity warrants in connection with convertible debt             679,577             $ 679,577
Termination of shares issued during merger under FPA agreement             140,572             140,572
Discretionary share issuance     $ 202         (202)            
Discretionary share issuance (in Shares)     2,023,031                              
Issuance of common shares in connection with warrant exercises     $ 1,096         12,924,033             12,925,129
Issuance of common shares in connection with warrant exercises (in Shares)     10,958,681                              
Issuance of common shares in connection with stock subscriptions     $ 625         499,375             500,000
Issuance of common shares in connection with stock subscriptions (in Shares)     6,250,000                              
Common shares to be issued for consulting services                 516,000         516,000
Conversion of Preferred B Shares to common stock     $ 625         (625)            
Conversion of Preferred B Shares to common stock (in Shares)     6,250,000     (500)                        
Issuance of Preferred B stock for cash             500,000             500,000
Issuance of Preferred B stock for cash (in Shares)         500                        
Forward purchase share contract     $ 675         (675)            
Forward purchase share contract (in Shares)     6,745,000                              
Debt conversion settlement     $ 200         1,177,800             1,178,000
Debt conversion settlement (in Shares)     2,000,000                              
Sales of common stock through At-the-Market facility     $ 221         1,112,524             1,112,745
Sales of common stock through At-the-Market facility (in Shares)     2,206,930                              
Deemed dividend - warrant modification             (1,530,910)             (1,530,910)
Net loss                     (10,551,674)     (10,551,674)
Balance at Dec. 31, 2025     $ 7,254           $ 30,054,695     $ 516,000     $ (21,114,473)     $ 9,463,476
Balance (in Shares) at Dec. 31, 2025     72,536,722                              
[1] Note: because of the business combination as recast, the shares of the Company’s common stock prior to the Business Combination (refer to Note 1) have been retrospectively recast to reflect the change in the capital structure.